SpyGlass Pharma SGP
NASDAQ SGP
$24.92 -1.58 (-5.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

SpyGlass Pharma (SGP) Net Income towards Common Stockholders (2025 - 2026)

Updated

SpyGlass Pharma (SGP) posted Net Income towards Common Stockholders of -$19.86 million for Q2 2026, compared with -$8.68 million a year earlier.

Analysis

SpyGlass Pharma (SGP) Net Income towards Common Stockholders (2025 - 2026) Analysis & Trends

For FY2025, SpyGlass Pharma's Net Income towards Common Stockholders came in at -$39.87 million.

  • In prior years, SpyGlass Pharma's Net Income towards Common Stockholders was -$29.16 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.61 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -248.00 Mn
10 SpyGlass Pharma 833.48 Mn 833.48 Mn - -19.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.86 Mn
Jun 30, 2025 -8.68 Mn
API Access

SpyGlass Pharma Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=SGP&period=max&api_key=YOUR_API_KEY